NIH-funded research R01 grant

Fasting blood sugar control in people with and without prediabetes

Official title: The regulation of fasting glucose metabolism in people with and without prediabetes

Funded at Mayo Clinic Rochester · NIH-11100011 · Data updated 2026-11-12

This project looks at how the hormones insulin and glucagon affect fasting blood sugar in adults with and without prediabetes.

More Prediabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startAugust 1, 2007
Project endMay 31, 2029
Funding year2025
Award (this year)$667,267
NIH project number5R01DK078646-19
Project IDNIH-11100011 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with prediabetes or with normal fasting glucose who can undergo detailed metabolic blood testing at Mayo Clinic Rochester.

Less likely to help

Children, people with type 1 diabetes, and those with longstanding or insulin-treated type 2 diabetes are unlikely to be eligible or to benefit from findings focused on early fasting hyperglycemia.

What this research studies

I would have blood drawn over time so researchers can measure insulin, glucagon, and glucose and see how those hormones act on fasting blood sugar. The team will test how glucagon changes glucose directly and indirectly through insulin, and how insulin changes glucose directly and indirectly through glucagon. They will use a new method to measure rapid hormone pulse patterns from the pancreas to find early signs of islet cell problems. Comparing people with normal glucose and those with prediabetes aims to pinpoint what changes lead to fasting high blood sugar before full diabetes develops.

Why it matters

Potential benefit: If successful, this work could reveal early hormone changes that predict or cause fasting high blood sugar and guide new prevention or treatment strategies.

How similar studies have gone: Prior studies show insulin and glucagon interact to control glucose, but using hormone-pulse measurements is a newer approach aimed at detecting earlier islet dysfunction.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Vella, Adrian — Mayo Clinic Rochester
  • Study coordinator: Vella, Adrian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.